Skip to main content

NASDAQ:ARCT Stock Forecast, Price Targets (Buy or Sell) | ARCT Arcturus Therapeutics Holdings Inc. Analyst Ratings



If, for example, a facility matured in 18 months, we could include the borrowing availability as a source of liquidity in year one, but exclude the amount in year two under the exceptional and strong descriptors (as well as include any drawn portions as debt maturities under uses of liquidity). This is because we do not assume an extension of bank lines--regardless of the company's perceived credit strength or issuer credit rating. For instance, whether the issuer credit rating on the company is speculative grade or investment grade, we do not assume bank lines will be extended beyond the current stated maturity.

We estimate ARCT Arcturus Therapeutics Holdings Inc. stock forecast parameters by: Bollinger Bands with Independent T-Test



ARCT Arcturus Therapeutics Holdings Inc. Stock Forecast (Buy or Sell) as of 12 May 2022 for (n+30)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with Bollinger Bands and Independent T-Test. Machine Learning based stock forecast (n+30) for ARCT Arcturus Therapeutics Holdings Inc. as below:

Time series to forecast n: 12 May 2022 for (n+30)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %


 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |